Synthesis, antiviral and cytostatic activities, of carbocyclic nucleosides incorporating a modified cyclopentane ring.: IV.: Adenosine and uridine analogues

被引:27
作者
Nieto, MI
Caamaño, O
Fernández, F
Gómez, M
Balzarini, J
De Clercq, E
机构
[1] Univ Santiago, Fac Farm, Dept Quim Organ, E-15782 Santiago De Compostela, Spain
[2] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
D O I
10.1081/NCN-120003289
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Eight new carbocyclic nucleosides were prepared by mounting a purine (compounds 8-10), 8-azapurine (12 and 13) or pyrimidine (15, 16 and 17b) on the amino group of (1S,3R)-3-aminomethyl-2,2,3-trimethyl-cyclopentylmethanol (6). All the compounds were evaluated as antiviral and antitumor agents in a variety of assay systems. Only compound 8 showed any cytostatic activity against the tumor cell lines examined.
引用
收藏
页码:243 / 255
页数:13
相关论文
共 24 条
[1]   SYNTHESIS OF CARBOCYCLIC NUCLEOSIDES [J].
AGROFOGLIO, L ;
SUHAS, E ;
FARESE, A ;
CONDOM, R ;
CHALLAND, SR ;
EARL, RA ;
GUEDJ, R .
TETRAHEDRON, 1994, 50 (36) :10611-10670
[2]   Synthesis and antiviral and cytostatic activities of carbocyclic nucleosides incorporating a modified cyclopentane ring .1. Guanosine analogues. [J].
Blanco, JM ;
Caamano, O ;
Fernandez, F ;
Gomez, G ;
Nieto, MI ;
Balzarini, J ;
Padalko, E ;
DeClercq, E .
NUCLEOSIDES & NUCLEOTIDES, 1997, 16 (1-2) :159-171
[3]   SYNTHESIS OF CHIRAL CARBOCYCLIC NUCLEOSIDES [J].
BORTHWICK, AD ;
BIGGADIKE, K .
TETRAHEDRON, 1992, 48 (04) :571-623
[4]   SYNTHESIS OF (1R,CIS)-3-AMINOMETHYL-1,2,2-TRIMETHYLCYCLOPENTANE-METHANOL - 2 APPROACHES USING ALPHA-CAMPHIDONE [J].
CAAMANO, O ;
FERNANDEZ, F ;
GOMEZ, G ;
NIETO, I .
TETRAHEDRON, 1994, 50 (07) :2175-2182
[5]   An efficient, scalable synthesis of the HIV reverse transcriptase inhibitor Ziagen® (1592U89) [J].
Daluge, SM ;
Martin, MT ;
Sickles, BR ;
Livingston, DA .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2000, 19 (1-2) :297-327
[6]   1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity [J].
Daluge, SM ;
Good, SS ;
Faletto, MB ;
Miller, WH ;
StClair, MH ;
Boone, LR ;
Tisdale, M ;
Parry, NR ;
Reardon, JE ;
Dornsife, RE ;
Averett, DR ;
Krenitsky, TA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1082-1093
[7]  
Fernández F, 2001, SYNTHESIS-STUTTGART, P239
[8]   NOVEL NUCLEOSIDE STRATEGIES FOR ANTI-HIV AND ANTI-HSV THERAPY [J].
HERDEWIJN, PAMM .
ANTIVIRAL RESEARCH, 1992, 19 (01) :1-14
[9]   Abacavir - A review of its clinical potential in patients with HIV infection [J].
Hervey, PS ;
Perry, CM .
DRUGS, 2000, 60 (02) :447-479
[10]   Homo-N-nucleosides: Incorporation into oligonucleotides and antiviral activity. [J].
Hossain, N ;
Hendrix, C ;
Lescrinier, E ;
VanAerschot, A ;
Busson, R ;
DeClercq, E ;
Herdewijn, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (13) :1465-1468